mechanism 1,475 words KG: ent-dise-39c8f1c5
Contents

Frontal and Temporal Lobe Selective Vulnerability in FTD

Mechanism Info
Nameent-dise-39c8f1c5

No AI portrait yet

Knowledge Graph

Related Hypotheses (19)

Purinergic Signaling Polarization Control
Score: 0.71
Mechanosensitive Ion Channel Reprogramming
Score: 0.70
Lipid Droplet Dynamics as Phenotype Switches
Score: 0.67
VCP-Mediated Autophagy Enhancement
Score: 0.59
Prefrontal sensory gating circuit restoration via PV interne
Score: 0.78
Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.95
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.79
HDAC3-Selective Inhibition for Clock Reset
Score: 0.71
CX43 hemichannel engineering enables size-selective mitochon
Score: 0.69
Pericyte Contractility Reset via Selective PDGFR-β Agonism
Score: 0.68
Osmotic Gradient Restoration via Selective AQP1 Enhancement
Score: 0.68
Temporal Decoupling via Circadian Clock Reset
Score: 0.54
Selective TLR4 Modulation to Prevent Gut-Derived Neuroinflam
Score: 0.79
Selective HDAC3 Inhibition with Cognitive Enhancement
Score: 0.78
...
Score: 0.68
Excitatory Neuron Vulnerability via SLC17A7 Downregulation
Score: 0.67
Temporal TET2-Mediated Hydroxymethylation Cycling
Score: 0.66
Oligodendrocyte White Matter Vulnerability
Score: 0.65
TREM2-Mediated Selective Aggregate Clearance Pathway
Score: 0.58

Related Analyses (30)

RNA binding protein dysregulation across ALS FTD AD
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · completed
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · completed
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived

Related Experiments (11)

Progranulin Replacement Therapy for FTD — Vector Development
clinical · proposed · Score: 0.40
Frontal and Temporal Lobe Selective Vulnerability in FTD — M
validation · proposed · Score: 0.40
FTD Microglia Role: Protective vs Destructive Mechanism Stud
validation · proposed · Score: 0.40
Cytochrome Therapeutics
clinical · proposed · Score: 0.40
Autophagy Enhancement Drug Screening for Neurodegeneration
clinical · proposed · Score: 0.40

See Also (15)

Alpha-Synuclein PET Imaging and Biomarker Advances
biomarker · Pages share 3 hypotheses
Alpha-Synuclein Seeding Assays (RT-QuIC and PMCA)
biomarker · Pages share 3 hypotheses
Imaging Biomarkers for Corticobasal Syndrome and Progre
biomarker · Pages share 3 hypotheses
Cell-Free DNA Biomarkers in Neurodegeneration
biomarker · Pages share 3 hypotheses
Exosomal Biomarkers in Neurodegeneration
biomarker · Pages share 3 hypotheses

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)